Phase I/II study of the combination of docetaxel, CDDP and S-1 in patients with unresectable advanced gastric cancer.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 17 Jul 2013
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 04 Jun 2009 New trial record.